Literature DB >> 18971355

Scavenging superoxide selectively in mouse forebrain is associated with improved cardiac function and survival following myocardial infarction.

Timothy E Lindley1, David W Infanger, Mark Rishniw, Yi Zhou, Marc F Doobay, Ram V Sharma, Robin L Davisson.   

Abstract

Dysregulation in central nervous system (CNS) signaling that results in chronic sympathetic hyperactivity is now recognized to play a critical role in the pathogenesis of heart failure (HF) following myocardial infarction (MI). We recently demonstrated that adenovirus-mediated gene transfer of cytoplasmic superoxide dismutase (Ad-Cu/ZnSOD) to forebrain circumventricular organs, unique sensory structures that lack a blood-brain barrier and link peripheral blood-borne signals to central nervous system cardiovascular circuits, inhibits both the MI-induced activation of these central signaling pathways and the accompanying sympathoexcitation. Here, we tested the hypothesis that this forebrain-targeted reduction in oxidative stress translates into amelioration of the post-MI decline in myocardial function and increase in mortality. Adult C57BL/6 mice underwent left coronary artery ligation or sham surgery along with forebrain-targeted gene transfer of Ad-Cu/ZnSOD or a control vector. The results demonstrate marked MI-induced increases in superoxide radical formation in one of these forebrain regions, the subfornical organ (SFO). Ad-Cu/ZnSOD targeted to this region abolished the increased superoxide levels and led to significantly improved myocardial function compared with control vector-treated mice. This was accompanied by diminished levels of cardiomyocyte apoptosis in the Ad-Cu/ZnSOD but not the control vector-treated group. These effects of superoxide scavenging with Ad-Cu/ZnSOD in the forebrain paralleled increased post-MI survival rates compared with controls. This suggests that oxidative stress in the SFO plays a critical role in the deterioration of cardiac function following MI and underscores the promise of CNS-targeted antioxidant therapy for the treatment of MI-induced HF.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18971355      PMCID: PMC2636979          DOI: 10.1152/ajpregu.00078.2008

Source DB:  PubMed          Journal:  Am J Physiol Regul Integr Comp Physiol        ISSN: 0363-6119            Impact factor:   3.619


  35 in total

1.  Inhibition of plasminogen activators or matrix metalloproteinases prevents cardiac rupture but impairs therapeutic angiogenesis and causes cardiac failure.

Authors:  S Heymans; A Luttun; D Nuyens; G Theilmeier; E Creemers; L Moons; G D Dyspersin; J P Cleutjens; M Shipley; A Angellilo; M Levi; O Nübe; A Baker; E Keshet; F Lupu; J M Herbert; J F Smits; S D Shapiro; M Baes; M Borgers; D Collen; M J Daemen; P Carmeliet
Journal:  Nat Med       Date:  1999-10       Impact factor: 53.440

2.  Chronic myocardial infarction in the mouse: cardiac structural and functional changes.

Authors:  E Lutgens; M J Daemen; E D de Muinck; J Debets; P Leenders; J F Smits
Journal:  Cardiovasc Res       Date:  1999-03       Impact factor: 10.787

3.  Chronic oxidative stress in the RVLM modulates sympathetic control of circulation in pigs.

Authors:  J Zanzinger; J Czachurski
Journal:  Pflugers Arch       Date:  2000-02       Impact factor: 3.657

Review 4.  Update on therapy for heart failure.

Authors:  Robert DiBianco
Journal:  Am J Med       Date:  2003-10-15       Impact factor: 4.965

Review 5.  Use of echocardiography for the phenotypic assessment of genetically altered mice.

Authors:  Keith A Collins; Claudia E Korcarz; Roberto M Lang
Journal:  Physiol Genomics       Date:  2003-05-13       Impact factor: 3.107

6.  A mechanistic role for cardiac myocyte apoptosis in heart failure.

Authors:  Detlef Wencker; Madhulika Chandra; Khanh Nguyen; Wenfeng Miao; Stavros Garantziotis; Stephen M Factor; Jamshid Shirani; Robert C Armstrong; Richard N Kitsis
Journal:  J Clin Invest       Date:  2003-05       Impact factor: 14.808

7.  Central Tempol alters basal sympathetic nerve discharge and attenuates sympathetic excitation to central ANG II.

Authors:  Ning Lu; Bryan G Helwig; Richard J Fels; Sujatha Parimi; Michael J Kenney
Journal:  Am J Physiol Heart Circ Physiol       Date:  2004-07-29       Impact factor: 4.733

8.  Adverse mortality effect of central sympathetic inhibition with sustained-release moxonidine in patients with heart failure (MOXCON).

Authors:  Jay N Cohn; Marc A Pfeffer; Jean Rouleau; Norman Sharpe; Karl Swedberg; Matthias Straub; Curtis Wiltse; Theressa J Wright
Journal:  Eur J Heart Fail       Date:  2003-10       Impact factor: 15.534

Review 9.  Heart failure and the brain: new perspectives.

Authors:  Robert B Felder; Joseph Francis; Zhi-Hua Zhang; Shun-Guang Wei; Robert M Weiss; Alan Kim Johnson
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2003-02       Impact factor: 3.619

10.  The data monitoring experience in the MOXCON trial.

Authors:  Stuart Pocock; Lars Wilhelmsen; Kenneth Dickstein; Gary Francis; Janet Wittes
Journal:  Eur Heart J       Date:  2004-11       Impact factor: 29.983

View more
  26 in total

1.  The attenuation of central angiotensin II-dependent pressor response and intra-neuronal signaling by intracarotid injection of nanoformulated copper/zinc superoxide dismutase.

Authors:  Erin G Rosenbaugh; James W Roat; Lie Gao; Rui-Fang Yang; Devika S Manickam; Jing-Xiang Yin; Harold D Schultz; Tatiana K Bronich; Elena V Batrakova; Alexander V Kabanov; Irving H Zucker; Matthew C Zimmerman
Journal:  Biomaterials       Date:  2010-04-07       Impact factor: 12.479

Review 2.  The brain renin-angiotensin-aldosterone system: a major mechanism for sympathetic hyperactivity and left ventricular remodeling and dysfunction after myocardial infarction.

Authors:  Bing S Huang; Frans H H Leenen
Journal:  Curr Heart Fail Rep       Date:  2009-06

Review 3.  Central nervous system circuits modified in heart failure: pathophysiology and therapeutic implications.

Authors:  Bernardo Sousa-Pinto; Manuel J Ferreira-Pinto; Mário Santos; Adelino F Leite-Moreira
Journal:  Heart Fail Rev       Date:  2014-11       Impact factor: 4.214

Review 4.  Neurohumoral stimulation.

Authors:  Irving H Zucker; Kaushik P Patel; Harold D Schultz
Journal:  Heart Fail Clin       Date:  2012-01       Impact factor: 3.179

5.  Mitochondrial-localized NADPH oxidase 4 is a source of superoxide in angiotensin II-stimulated neurons.

Authors:  Adam J Case; Shumin Li; Urmi Basu; Jun Tian; Matthew C Zimmerman
Journal:  Am J Physiol Heart Circ Physiol       Date:  2013-04-26       Impact factor: 4.733

Review 6.  Cardiovascular injury induced by tobacco products: assessment of risk factors and biomarkers of harm. A Tobacco Centers of Regulatory Science compilation.

Authors:  Daniel J Conklin; Suzaynn Schick; Michael J Blaha; Alex Carll; Andrew DeFilippis; Peter Ganz; Michael E Hall; Naomi Hamburg; Tim O'Toole; Lindsay Reynolds; Sanjay Srivastava; Aruni Bhatnagar
Journal:  Am J Physiol Heart Circ Physiol       Date:  2019-02-01       Impact factor: 4.733

7.  Subfornical organ mediates sympathetic and hemodynamic responses to blood-borne proinflammatory cytokines.

Authors:  Shun-Guang Wei; Zhi-Hua Zhang; Terry G Beltz; Yang Yu; Alan Kim Johnson; Robert B Felder
Journal:  Hypertension       Date:  2013-05-13       Impact factor: 10.190

Review 8.  Regulation of central angiotensin type 1 receptors and sympathetic outflow in heart failure.

Authors:  Irving H Zucker; Harold D Schultz; Kaushik P Patel; Wei Wang; Lie Gao
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-08-28       Impact factor: 4.733

9.  Central Rho kinase inhibition restores baroreflex sensitivity and angiotensin II type 1 receptor protein imbalance in conscious rabbits with chronic heart failure.

Authors:  Karla K V Haack; Lie Gao; Alicia M Schiller; Pamela L Curry; Peter R Pellegrino; Irving H Zucker
Journal:  Hypertension       Date:  2013-01-02       Impact factor: 10.190

10.  Blood-borne interleukin-1β acts on the subfornical organ to upregulate the sympathoexcitatory milieu of the hypothalamic paraventricular nucleus.

Authors:  Shun-Guang Wei; Yang Yu; Robert B Felder
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2017-11-22       Impact factor: 3.619

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.